Proshares Trust ZBIO
ZBIO
$28.78 +0.60 (+2.13%)
As of: Oct 21, 2026 · 1:11 PM EDT

Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2026)

Updated

Zenas BioPharma (ZBIO) reported Capital Expenditures of $2,000 for Q1 2026, down 88.9% from $18,000 a year earlier.

Analysis

Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2026) Analysis & Trends

For FY2025, Zenas BioPharma posted Capital Expenditures of $18,000, down 86.3% from FY2024.

  • By year, Capital Expenditures came in at $131,000 in FY2024 (+670.6%) and $17,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,133.02 Bn 1,101.60 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 1.32 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 322.00 Mn
4 Merck 366.78 Bn 321.16 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 1.86 Bn
7 Amgen 235.44 Bn 190.84 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 190.69 Bn 164.89 Bn 6.22 Bn 140.00 Mn
9 Pfizer 169.52 Bn 116.16 Bn 10.94 Bn 533.00 Mn
10 Zenas BioPharma 1.81 Bn 1.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2,000.00
Mar 31, 2025 18,000.00
Dec 31, 2024 74,000.00
Jun 30, 2024 35,000.00
Mar 31, 2024 22,000.00
API Access

Zenas BioPharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ZBIO&period=max&api_key=YOUR_API_KEY